Literature DB >> 27863901

A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Lama M Chahine1, Amy W Amara2, Aleksandar Videnovic3.   

Abstract

Sleep disorders are among the most common non-motor manifestations in Parkinson's disease (PD) and have a significant negative impact on quality of life. While sleep disorders in PD share most characteristics with those that occur in the general population, there are several considerations specific to this patient population regarding diagnosis, management, and implications. The available research on these disorders is expanding rapidly, but many questions remain unanswered. We thus conducted a systematic review of the literature published from 2005 to 2015 on the following disorders of sleep and wakefulness in PD: REM sleep behavior disorder, insomnia, nocturia, restless legs syndrome and periodic limb movements, sleep disordered breathing, excessive daytime sleepiness, and circadian rhythm disorders. We discuss the epidemiology, etiology, clinical implications, associated features, evaluation measures, and management of these disorders. The influence on sleep of medications used in the treatment of motor and non-motor symptoms of PD is detailed. Additionally, we suggest areas in need of further research.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Circadian rhythm disorders; Excessive daytime sleepiness; Insomnia; Parkinson's disease; Periodic limb movements; REM sleep behavior disorder; Restless legs syndrome; Sleep and neurodegeneration; Sleep disordered breathing

Mesh:

Year:  2016        PMID: 27863901      PMCID: PMC5332351          DOI: 10.1016/j.smrv.2016.08.001

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  343 in total

1.  Clinical correlates of periodic limb movements in sleep in Parkinson's disease.

Authors:  Naima Covassin; Ariel B Neikrug; Lianqi Liu; Jody Corey-Bloom; Jose S Loredo; Barton W Palmer; Jeanne Maglione; Sonia Ancoli-Israel
Journal:  J Neurol Sci       Date:  2012-01-25       Impact factor: 3.181

2.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

3.  Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.

Authors:  Nico J Weerkamp; Gerrit Tissingh; Petra J E Poels; Systse U Zuidema; Marten Munneke; Raymond T C M Koopmans; Bastiaan R Bloem
Journal:  J Am Geriatr Soc       Date:  2013-10-01       Impact factor: 5.562

4.  Daytime sleep in Parkinson's disease measured by episodes of immobility.

Authors:  K Kotschet; W Johnson; S McGregor; J Kettlewell; A Kyoong; D M O'Driscoll; A R Turton; R I Griffiths; M K Horne
Journal:  Parkinsonism Relat Disord       Date:  2014-02-24       Impact factor: 4.891

5.  The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease.

Authors:  Jules M Nazzaro; Rajesh Pahwa; Kelly E Lyons
Journal:  Parkinsonism Relat Disord       Date:  2011-06-12       Impact factor: 4.891

6.  Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies.

Authors:  Michele Terzaghi; Dario Arnaldi; Maria Cristina Rizzetti; Brigida Minafra; Riccardo Cremascoli; Valter Rustioni; Roberta Zangaglia; Chiara Pasotti; Elena Sinforiani; Claudio Pacchetti; Raffaele Manni
Journal:  Mov Disord       Date:  2013-06-06       Impact factor: 10.338

7.  A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Authors:  I H Richard; M P McDermott; R Kurlan; J M Lyness; P G Como; N Pearson; S A Factor; J Juncos; C Serrano Ramos; M Brodsky; C Manning; L Marsh; L Shulman; H H Fernandez; K J Black; M Panisset; C W Christine; W Jiang; C Singer; S Horn; R Pfeiffer; D Rottenberg; J Slevin; L Elmer; D Press; H C Hyson; W McDonald
Journal:  Neurology       Date:  2012-04-11       Impact factor: 9.910

8.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Authors:  B F Boeve; M H Silber; T J Ferman; S C Lin; E E Benarroch; A M Schmeichel; J E Ahlskog; R J Caselli; S Jacobson; M Sabbagh; C Adler; B Woodruff; T G Beach; A Iranzo; E Gelpi; J Santamaria; E Tolosa; C Singer; D C Mash; C Luca; I Arnulf; C Duyckaerts; C H Schenck; M W Mahowald; Y Dauvilliers; N R Graff-Radford; Z K Wszolek; J E Parisi; B Dugger; M E Murray; D W Dickson
Journal:  Sleep Med       Date:  2013-03-07       Impact factor: 3.492

9.  REM sleep behavior disorder in Parkinson disease: association with abnormal ocular motor findings.

Authors:  Young Eun Kim; Hui June Yang; Ji Young Yun; Han-Joon Kim; Jee-Young Lee; Beom S Jeon
Journal:  Parkinsonism Relat Disord       Date:  2013-12-16       Impact factor: 4.891

10.  How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.

Authors:  R B Postuma; A E Lang; J F Gagnon; A Pelletier; J Y Montplaisir
Journal:  Brain       Date:  2012-05-04       Impact factor: 13.501

View more
  91 in total

Review 1.  Idiopathic Hypersomnia.

Authors:  Lynn Marie Trotti
Journal:  Sleep Med Clin       Date:  2017-06-16

2.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

Review 3.  Association between circadian rhythms and neurodegenerative diseases.

Authors:  Yue Leng; Erik S Musiek; Kun Hu; Francesco P Cappuccio; Kristine Yaffe
Journal:  Lancet Neurol       Date:  2019-02-12       Impact factor: 44.182

4.  Basal ganglia beta oscillations during sleep underlie Parkinsonian insomnia.

Authors:  Aviv D Mizrahi-Kliger; Alexander Kaplan; Zvi Israel; Marc Deffains; Hagai Bergman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-07       Impact factor: 11.205

5.  Diagnostic accuracy of REM sleep behaviour disorder screening questionnaire: a meta-analysis.

Authors:  Kai Li; Shu-Hua Li; Wen Su; Hai-Bo Chen
Journal:  Neurol Sci       Date:  2017-03-17       Impact factor: 3.307

6.  Presleep Cognitive Arousal and Insomnia Comorbid to Parkinson Disease: Evidence for a Serial Mediation Model of Sleep-Related Safety Behaviors and Dysfunctional Beliefs About Sleep.

Authors:  Cindy Lebrun; Marie-Christine Gély-Nargeot; Khaalid Hassan Maudarbocus; Alexia Rossignol; Christian Geny; Sophie Bayard
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

7.  Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism.

Authors:  Mo Xu; Jerry K Bohlen; Cynthia Moore; Michelle A Nipper; Deborah A Finn; Carolyn E Jones; Miranda M Lim; Charles K Meshul
Journal:  J Neurosci Res       Date:  2019-09-18       Impact factor: 4.164

Review 8.  Treatment of Sleep Dysfunction in Parkinson's Disease.

Authors:  Amy W Amara; Lana M Chahine; Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2017-07       Impact factor: 3.598

Review 9.  Effects of exercise on sleep in neurodegenerative disease.

Authors:  Adeel A Memon; Juliana J Coleman; Amy W Amara
Journal:  Neurobiol Dis       Date:  2020-04-01       Impact factor: 5.996

10.  Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.

Authors:  Fabian Büchele; Marc Hackius; Sebastian R Schreglmann; Wolfgang Omlor; Esther Werth; Angelina Maric; Lukas L Imbach; Stefan Hägele-Link; Daniel Waldvogel; Christian R Baumann
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.